Sex-dependent effects of chronic variable stress on discrete corticotropin-releasing factor receptor 1 cell populations.


Journal

Physiology & behavior
ISSN: 1873-507X
Titre abrégé: Physiol Behav
Pays: United States
ID NLM: 0151504

Informations de publication

Date de publication:
15 05 2020
Historique:
received: 15 11 2019
revised: 25 01 2020
accepted: 13 02 2020
pubmed: 23 2 2020
medline: 22 6 2021
entrez: 22 2 2020
Statut: ppublish

Résumé

Anxiety and depression are strikingly more prevalent in women compared with men. Dysregulation of corticotropin-releasing factor (CRF) binding to its cognate receptor (CRFR1) is thought to play a critical role in the etiology of these disorders. In the present study, we investigated whether there were sex differences in the effects of chronic variable stress (CVS) on CRFR1 cells using CRFR1-GFP reporter mice experiencing a 9-day CVS paradigm. Brains were collected from CVS and stress naïve female and male mice following exposure to the open field test. This CVS paradigm effectively increased anxiety-like behavior in female and male mice. In addition, we assessed changes in activation of CRFR1 cells (co-localization with c-Fos and phosphorylated CREB (pCREB)) in stress associated brain structures, including two sexually dimorphic CRFR1 cell groups in the anteroventral periventricular nucleus (AVPV/PeN; F>M) and paraventricular hypothalamus (PVN; M>F). CVS increased CRFR1-GFP cell number as well as the number of CRFR1/pCREB co-expressing cells in the female but not male AVPV/PeN. In the PVN, the number of CRFR1/pCREB co-expressing cells was overall greater in males regardless of treatment and CVS resulted in a male-specific reduction of CRFR1/c-Fos cells. In addition, CVS induced a female-specific reduction in CRFR1/c-Fos cells within the anteroventral bed nucleus of the stria terminalis and both sexes exhibited a reduction in CRFR1/c-Fos co-expressing cells following CVS within the ventral basolateral amygdala. Overall, these sex-specific effects of CVS on CRFR1 populations may have implications for sex differences in stress-induction of mood disorders.

Identifiants

pubmed: 32081812
pii: S0031-9384(20)30164-5
doi: 10.1016/j.physbeh.2020.112847
pmc: PMC7540729
mid: NIHMS1568163
pii:
doi:

Substances chimiques

Receptors, Corticotropin-Releasing Hormone 0
CRF receptor type 1 5CLY6W2H1M
Corticotropin-Releasing Hormone 9015-71-8

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112847

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD097331
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC017149
Pays : United States
Organisme : NIMH NIH HHS
ID : R15 MH118692
Pays : United States
Organisme : NICHD NIH HHS
ID : R15 HD096411
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH112768
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Ann N Y Acad Sci. 1995 Dec 29;771:92-104
pubmed: 8597448
J Neuroendocrinol. 2001 May;13(5):442-52
pubmed: 11328455
Brain Res Mol Brain Res. 1989 Dec;6(4):297-310
pubmed: 2574404
Neuroscience. 2006 Nov 3;142(4):1281-92
pubmed: 16938401
Nat Rev Endocrinol. 2009 Jul;5(7):374-81
pubmed: 19488073
Exp Neurol. 2019 Nov;321:113030
pubmed: 31377402
Endocrinology. 2009 Jan;150(1):153-60
pubmed: 18787020
Brain Res. 2017 Dec 15;1677:74-85
pubmed: 28941573
J Neurosci. 2019 Feb 6;39(6):1030-1043
pubmed: 30530860
J Neurosci. 1994 Sep;14(9):5623-34
pubmed: 8083758
J Clin Invest. 2015 Jan;125(1):337-49
pubmed: 25485685
Neuroscience. 2009 Dec 15;164(3):963-74
pubmed: 19706319
J Affect Disord. 2016 Nov 15;205:282-288
pubmed: 27544317
Behav Brain Res. 2018 Feb 15;338:134-142
pubmed: 29080675
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 10;88:303-310
pubmed: 30096330
Horm Behav. 2005 Jun;48(1):64-74
pubmed: 15919386
Physiol Behav. 2005 Jun 30;85(3):363-9
pubmed: 15939444
Brain Res Rev. 2008 Mar;57(2):277-87
pubmed: 17604108
Ann N Y Acad Sci. 2008 Dec;1148:57-63
pubmed: 19120091
Nature. 2015 Sep 24;525(7570):519-22
pubmed: 26375004
Front Neuroendocrinol. 2013 Jan;34(1):3-17
pubmed: 22728025
Brain Struct Funct. 2018 Jul;223(6):2685-2698
pubmed: 29569009
Psychoneuroendocrinology. 2014 Sep;47:151-65
pubmed: 25001965
Nature. 1988 Aug 11;334(6182):494-8
pubmed: 2900470
J Neurosci. 2018 Feb 21;38(8):1874-1890
pubmed: 29352046
J Comp Neurol. 2008 Dec 1;511(4):479-96
pubmed: 18853426
Nat Rev Mol Cell Biol. 2001 Aug;2(8):599-609
pubmed: 11483993
Neuropharmacology. 2015 Oct;97:346-56
pubmed: 26107116
Eur J Pharmacol. 2003 Feb 28;463(1-3):199-216
pubmed: 12600711
Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13666-71
pubmed: 15342910
Neuroendocrinology. 1995 Feb;61(2):180-90
pubmed: 7753337
Physiol Behav. 2011 Aug 3;104(2):242-7
pubmed: 21315096
Endocrinology. 2008 Feb;149(2):818-26
pubmed: 18039788
J Comp Neurol. 1988 Mar 15;269(3):381-91
pubmed: 3372720
Neuroscience. 2017 Oct 11;361:167-178
pubmed: 28823817
Neurobiol Stress. 2019 Aug 10;11:100192
pubmed: 31516918
Behav Brain Res. 2006 Nov 25;175(1):43-50
pubmed: 17023061
Endocrinology. 2002 Jul;143(7):2534-40
pubmed: 12072385
Endocrinology. 1993 Dec;133(6):3058-61
pubmed: 8243338
Front Mol Neurosci. 2015 Aug 26;8:46
pubmed: 26379491
Psychoneuroendocrinology. 2004 May;29(4):475-85
pubmed: 14749093
Mol Psychiatry. 2017 May;22(5):733-744
pubmed: 27595593
J Cell Commun Signal. 2013 Dec;7(4):295-300
pubmed: 23504413
Cereb Cortex. 2009 Sep;19(9):1978-89
pubmed: 19073626
Pharmacol Biochem Behav. 2000 Nov;67(3):587-96
pubmed: 11164090
Neuropharmacology. 2019 Aug;154:96-106
pubmed: 30266597
Neuron. 2002 Apr 25;34(3):371-85
pubmed: 11988169
Front Behav Neurosci. 2018 Jul 20;12:150
pubmed: 30079015
J Comp Neurol. 1997 Jul 21;384(1):142-64
pubmed: 9214545
Neuroscience. 2018 Jun 1;380:132-145
pubmed: 29679646
Biol Psychiatry. 2016 Nov 15;80(10):743-753
pubmed: 27318500
Biol Psychiatry. 2020 Mar 15;87(6):492-501
pubmed: 31601425
Biol Sex Differ. 2017 Jan 13;8:2
pubmed: 28101317
Biol Sex Differ. 2019 Jan 28;10(1):6
pubmed: 30691514
J Neuroendocrinol. 2002 Jun;14(6):506-13
pubmed: 12047726
Neurobiol Learn Mem. 2014 Jul;112:139-47
pubmed: 24508064
Science. 1993 Apr 9;260(5105):238-41
pubmed: 8097062
Psychoneuroendocrinology. 2016 Dec;74:302-307
pubmed: 27701044
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):14077-82
pubmed: 9391155
Endocrinology. 2016 Feb;157(2):764-73
pubmed: 26562258
Neuroscience. 2006 Dec 1;143(2):387-93
pubmed: 16962717
J Biol Chem. 1996 Jun 14;271(24):14214-20
pubmed: 8662977
Stress. 2009 Nov;12(6):469-77
pubmed: 20102318
J Clin Psychiatry. 2015 Feb;76(2):155-62
pubmed: 25742202
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Behav Neurosci. 2005 Dec;119(6):1448-58
pubmed: 16420149
Neuroscience. 2019 Jun 15;409:195-203
pubmed: 31055007
Physiol Behav. 2011 Aug 3;104(2):248-56
pubmed: 21396387
Brain Res. 2010 Dec 10;1364:153-63
pubmed: 20727865
Behav Brain Res. 2007 Aug 6;181(2):180-90
pubmed: 17517441
PLoS One. 2015 Apr 01;10(4):e0121125
pubmed: 25830629
Neuroscience. 2004;124(3):695-707
pubmed: 14980739
Neuropsychopharmacology. 2015 Sep;40(10):2443-53
pubmed: 25857685
J Neurosci. 2016 Apr 6;36(14):4093-105
pubmed: 27053215
PLoS One. 2011;6(11):e28128
pubmed: 22132228
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jul;28(4):699-707
pubmed: 15276696
Front Neuroendocrinol. 1994 Dec;15(4):321-50
pubmed: 7895891
Psychopharmacology (Berl). 2006 May;186(1):122-32
pubmed: 16568282
Nat Neurosci. 2017 Mar;20(3):385-388
pubmed: 28135239
Psychoneuroendocrinology. 2012 Jun;37(6):762-72
pubmed: 21974975
Mol Cell Biol. 1998 Feb;18(2):967-77
pubmed: 9447994
J Neuroendocrinol. 2015 Apr;27(4):264-76
pubmed: 25599767
Neuron. 1998 Jun;20(6):1093-102
pubmed: 9655498
eNeuro. 2016 Nov 2;3(5):
pubmed: 27844053
J Comp Neurol. 2019 Apr 15;527(6):1056-1069
pubmed: 30499109
J Neurosci. 2015 Dec 16;35(50):16362-76
pubmed: 26674863
J Affect Disord. 2000 Oct;60(1):1-11
pubmed: 10940442
Auton Neurosci. 2013 Apr;175(1-2):38-50
pubmed: 23260431
J Neurosci. 1985 Jan;5(1):40-7
pubmed: 3965644
Endocrinology. 2010 Apr;151(4):1784-94
pubmed: 20185764
Endocrinology. 2010 Dec;151(12):5807-17
pubmed: 20926580
Transl Psychiatry. 2014 Feb 11;4:e359
pubmed: 24518397
Horm Behav. 2008 Nov;54(5):758-66
pubmed: 18775430
J Neurochem. 2014 May;129(3):495-508
pubmed: 24400874
eNeuro. 2017 Jun 22;4(3):
pubmed: 28660243
Brain Res. 1985 Jan 28;325(1-2):391-4
pubmed: 3978433
Horm Behav. 2012 Aug;62(3):210-8
pubmed: 22426413

Auteurs

Zachary J Rosinger (ZJ)

Department of Psychology, University at Albany, Albany, NY 12222, United States.

Rose M De Guzman (RM)

Department of Psychology, University at Albany, Albany, NY 12222, United States.

Jason S Jacobskind (JS)

Department of Psychology, University at Albany, Albany, NY 12222, United States.

Brianna Saglimbeni (B)

Department of Psychology, University at Albany, Albany, NY 12222, United States.

Margaret Malone (M)

Department of Psychology, University at Albany, Albany, NY 12222, United States.

Danielle Fico (D)

Department of Psychology, University at Albany, Albany, NY 12222, United States.

Nicholas J Justice (NJ)

Center for Metabolic and Degenerative Diseases, Institute of Molecular Medicine, University of Texas Health Sciences Center, Houston, TX, United States.

Paolo E Forni (PE)

Department of Biological Sciences, The RNA Institute, and the Center for Neuroscience Research, University at Albany, State University of New York, Albany, NY 12222, United States.

Damian G Zuloaga (DG)

Department of Psychology, University at Albany, Albany, NY 12222, United States. Electronic address: dzuloaga@albany.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH